- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 301
IP Group unveils mid-year results
IP Group supplied less funding to its portfolio companies but witnessed a three-fold increase in cash realisations during the first half of 2019.
Sep 10, 2019Noske notches up an Alliance Ventures promotion
Ex-GCV Rising Star Christian Noske will head up the Renault-Nissan-Mitsubishi unit, less than two years after joining from BMW i Ventures.
Sep 10, 2019Parkwalk Opportunities EIS pours $65m into spinouts
Spinouts such as Oxford’s Moa Technology and Cambridge’s Paragraf were a focal point for Parkwalk Advisors’ largest EIS-assisted venture fund during the 2018-19 tax year.
Sep 9, 2019Volocopter reaches first close of series C
The Intel and Daimler-backed air taxi developer secured $55.2m in a tranche led by Geely Holding and intends to reach a final close later this year.
Sep 9, 2019Eggleston leaves BGF for Pantheon
John Eggleston has departed from his position as head of the tech sector for BGF in order to take up the chief technology officer role at Pantheon Ventures.
Sep 9, 2019Corporate venturing deal net: 2-6 September 2019
Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.
Sep 6, 2019Gyroscope spins to series B round
Gyroscope Therapeutics, a dry AMD treatment developer exploiting University of Cambridge research, has secured $61.2m from cornerstone investors Cambridge Innovation Capital and Syncona.
Sep 4, 2019DMGT drives Cazoo's latest round
Existing investor DMG Ventures has returned to back a $30.4m round for automotive e-commerce platform Cazoo, its second in nine months.
Sep 4, 2019Investors slip $23m to Elliptic
SBI Group and Santander InnoVentures backed a series B round that boosted cryptocurrency security tool developer Elliptic's funding to $30m altogether.
Sep 4, 2019Caldan calls in $2.4m
Leveraging University of Glasgow and University of Southern Denmark research, Caldan is targeting a free fatty acid receptor associated with fatty liver disease and type 2 diabetes.
Sep 4, 2019About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


